Kozo Morimoto

5.1k total citations
158 papers, 1.6k citations indexed

About

Kozo Morimoto is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kozo Morimoto has authored 158 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Epidemiology, 80 papers in Infectious Diseases and 45 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kozo Morimoto's work include Mycobacterium research and diagnosis (97 papers), Tuberculosis Research and Epidemiology (71 papers) and Infectious Diseases and Mycology (41 papers). Kozo Morimoto is often cited by papers focused on Mycobacterium research and diagnosis (97 papers), Tuberculosis Research and Epidemiology (71 papers) and Infectious Diseases and Mycology (41 papers). Kozo Morimoto collaborates with scholars based in Japan, United States and Netherlands. Kozo Morimoto's co-authors include Atsuyuki Kurashima, Takashi Yoshiyama, Satoshi Mitarai, Naoki Hasegawa, Kazuhiro Uchimura, Hideo Ogata, Shoji Kudoh, Kozo Yoshimori, Kiyohiko Izumi and Yoshihiko Hoshino and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Kozo Morimoto

128 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kozo Morimoto Japan 20 1.2k 874 486 290 228 158 1.6k
Eisaku Tanaka Japan 20 631 0.5× 461 0.5× 249 0.5× 666 2.3× 210 0.9× 76 1.5k
Yoshitaka Yamazaki Japan 19 610 0.5× 354 0.4× 133 0.3× 455 1.6× 226 1.0× 85 1.3k
Sarah K. Brode Canada 15 693 0.6× 514 0.6× 235 0.5× 183 0.6× 168 0.7× 55 960
Allison Handler United States 3 440 0.4× 264 0.3× 217 0.4× 405 1.4× 80 0.4× 5 818
Nobuyuki Kobayashi Japan 18 295 0.2× 307 0.4× 25 0.1× 140 0.5× 262 1.1× 51 800
Paul L. Williams United States 14 762 0.6× 641 0.7× 116 0.2× 55 0.2× 100 0.4× 20 965
Okan Elidemir United States 21 460 0.4× 205 0.2× 32 0.1× 481 1.7× 433 1.9× 57 1.2k
Senu Apewokin United States 15 396 0.3× 405 0.5× 54 0.1× 73 0.3× 71 0.3× 31 846
Ronei Luciano Mamoni Brazil 20 772 0.6× 459 0.5× 51 0.1× 81 0.3× 60 0.3× 51 1.5k
Jeong Kee Seo South Korea 23 321 0.3× 152 0.2× 74 0.2× 292 1.0× 959 4.2× 136 1.6k

Countries citing papers authored by Kozo Morimoto

Since Specialization
Citations

This map shows the geographic impact of Kozo Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kozo Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kozo Morimoto more than expected).

Fields of papers citing papers by Kozo Morimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kozo Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kozo Morimoto. The network helps show where Kozo Morimoto may publish in the future.

Co-authorship network of co-authors of Kozo Morimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Kozo Morimoto. A scholar is included among the top collaborators of Kozo Morimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kozo Morimoto. Kozo Morimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kodama, Tatsuya, Akio Aono, Keiji Fujiwara, et al.. (2025). Risk factors, molecular analysis and treatment outcomes of amikacin-resistant Mycobacterium avium complex pulmonary disease. ERJ Open Research. 11(4). 1084–2024.
2.
Ito, Masashi, Koji Furuuchi, Keiji Fujiwara, et al.. (2024). Epidemiological trends and clinical relevance of nontuberculous mycobacterial pulmonary disease in a referral hospital in Japan, 2017–2021. Respiratory Investigation. 62(6). 1064–1071.
3.
4.
Morimoto, Kozo, Jack R. Gallagher, Dirk Wagner, David E. Griffith, & Jakko van Ingen. (2024). Real-World Patients’ Diagnosis-to-Treatment Journey with Nontuberculous Mycobacterial Pulmonary Disease: A Cross-Sectional Survey. Infectious Diseases and Therapy. 13(8). 1907–1920. 3 indexed citations
5.
Metersky, Mark L., Pierre‐Régis Burgel, Charles L. Daley, et al.. (2024). ANNUALIZED EXACERBATION RATE IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS BY PRESPECIFIED SUBGROUPS IN THE PH3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED ASPEN TRIAL. CHEST Journal. 166(4). A6554–A6556. 2 indexed citations
6.
Fujiwara, Keiji, Koji Furuuchi, Masashi Ito, et al.. (2024). Beyond Symptoms: Radiologic identification of asymptomatic Mycobacterium avium complex pulmonary infections. Respiratory Medicine. 226. 107627–107627. 2 indexed citations
7.
Morimoto, Kozo, et al.. (2024). Laboratory-based surveillance of nontuberculous mycobacterial pulmonary disease in Japan. ERJ Open Research. 11(1). 337–2024. 1 indexed citations
8.
Shimoda, Masafumi, et al.. (2023). Diagnostic flowchart for tuberculous pleurisy, pleural infection, and malignant pleural effusion. Respiratory Investigation. 62(1). 157–163. 3 indexed citations
9.
Prevots, D. Rebecca, et al.. (2023). Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease. Clinics in Chest Medicine. 44(4). 675–721. 44 indexed citations
10.
Ito, Masashi, Koji Furuuchi, Keiji Fujiwara, et al.. (2023). Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease. Respiratory Medicine. 219. 107417–107417. 3 indexed citations
11.
Uwamino, Yoshifumi, Akio Aono, Kozo Morimoto, et al.. (2023). Diagnostic Utility of a Mycobacterium Multiplex PCR Detection Panel for Tuberculosis and Nontuberculous Mycobacterial Infections. Microbiology Spectrum. 11(3). e0516222–e0516222. 6 indexed citations
12.
Yoshida, Mitsunori, Jung‐Yien Chien, Kozo Morimoto, et al.. (2022). Molecular Epidemiological Characteristics of Mycobacterium abscessus Complex Derived from Non-Cystic Fibrosis Patients in Japan and Taiwan. Microbiology Spectrum. 10(3). e0057122–e0057122. 10 indexed citations
13.
Maki, Teruya, Jun Noda, Kozo Morimoto, et al.. (2022). Long-range transport of airborne bacteria over East Asia: Asian dust events carry potentially nontuberculous Mycobacterium populations. Environment International. 168. 107471–107471. 30 indexed citations
14.
Morimoto, Kozo, Kazuro Iwai, Takashi Yoshiyama, et al.. (2022). Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in Japan. ERJ Open Research. 9(1). 424–2022. 4 indexed citations
15.
Schildkraut, Jodie A., Jack R. Gallagher, Kozo Morimoto, et al.. (2020). Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation. Respiratory Medicine. 173. 106164–106164. 28 indexed citations
16.
Nakamoto, Keitaro, Yuka Sasaki, Tatsuya Shirai, et al.. (2019). ABSTRACT WITHDRAWN. Respirology. 24(S2). 21–21.
17.
Morimoto, Kozo, Kiyohiko Izumi, Manabu Ato, Naoki Hasegawa, & Satoshi Mitarai. (2019). Actual practice of standard treatment for pulmonary nontuberculous mycobacteriosis in Japan. Respiratory Medicine. 158. 67–69. 5 indexed citations
18.
Aono, Akio, Kozo Morimoto, Kinuyo Chikamatsu, et al.. (2018). Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae. Journal of Infection and Chemotherapy. 25(2). 117–123. 24 indexed citations
19.
Tsuyuguchi, Kazunari, Hideaki Nagai, Kenji Ogawa, et al.. (2016). Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB. Journal of Infection and Chemotherapy. 23(2). 101–106. 3 indexed citations
20.
Torizuka, K, K Uemura, Michio Toru, et al.. (1996). [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 2)--Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders].. PubMed. 33(3). 303–18. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eisaku Tanaka Breakdown of academic impact, for papers by Yoshitaka Yamazaki Breakdown of academic impact, for papers by Sarah K. Brode Breakdown of academic impact, for papers by Allison Handler Breakdown of academic impact, for papers by Nobuyuki Kobayashi Breakdown of academic impact, for papers by Paul L. Williams Breakdown of academic impact, for papers by Okan Elidemir Breakdown of academic impact, for papers by Senu Apewokin Breakdown of academic impact, for papers by Ronei Luciano Mamoni Breakdown of academic impact, for papers by Jeong Kee Seo
Rankless by CCL
2026